Amphastar Pharmaceuticals AMPH Finished Pharmaceutical Products — Advertising Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AdvertisingExpense.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
Advertising expenses, primarily associated with Primatene MIST®, are recorded as they are incurred, except for expenses related to the development of a major commercial or media campaign, which are expensed in the period in which the commercial or campaign is first presented, and are reflected as a component of selling, distribution and marketing in the Company’s condensed consolidated statements of operations. For the three and six months ended June 30, 2026, advertising expenses were $3.3 million and $5.8 million, respectively. For the three and six months ended June 30, 2025, advertising expenses were $2.5 million and $5.5 million, respectively.
Item 1. Financial Statements (unaudited)
FAQ
- What is Amphastar Pharmaceuticals's finished pharmaceutical products — advertising expense?
- Amphastar Pharmaceuticals (AMPH) reported finished pharmaceutical products — advertising expense of $3.3M in Q2 2026.
- How has Amphastar Pharmaceuticals's finished pharmaceutical products — advertising expense changed year-over-year?
- Amphastar Pharmaceuticals's finished pharmaceutical products — advertising expense increased by 32.0% year-over-year, from $2.5M to $3.3M.
- What is the long-term trend for Amphastar Pharmaceuticals's finished pharmaceutical products — advertising expense?
- Over 2 years (2021 to 2023), Amphastar Pharmaceuticals's finished pharmaceutical products — advertising expense has grown at a 13.3% compound annual growth rate (CAGR), from $8.1M to $10.4M.
- What does finished pharmaceutical products — advertising expense mean?
- This metric tracks the total costs incurred for marketing, promotional activities, and advertising campaigns specifically allocated to the finished pharmaceutical products segment. It measures the company's investment in brand awareness and market penetration to support the commercialization of its product offerings.
Ask your AI about Amphastar Pharmaceuticals's finished pharmaceutical products — advertising expense.
Connect your AI assistant and compare it to peers, right in your chat.
